Developer docs
API playgroundTry for free, no card

Search company profiles

CellDynamics iSrl

Full company profile

uuid000uy1w

Namestring
CellDynamics iSrl
Legal namestring
CellDynamics ISRL
Websiteurl
celldynamics.it
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBologna, Italy
HQ citystring
Bologna
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
3D cell analysis, organoid quantification, biophysical characterization, spheroid measurement instruments, lab automation hardware
Industry3 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAGAD
Organoids & Organ-on-Chip (regenerative models)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
Product category
Laboratory Instrumentation for 3D Cell Analysis
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1W8 Hardware and Software Sales
TypeHardware Sales
Description

CellDynamics designs, develops, produces, and markets the W8 instrument and associated software entirely in-house. Revenue is generated from the sale of the W8 platform to pharma, biotech, and academic research institutions for biophysical characterization of 3D cell models.

celldynamics.it
2CELLviewer Platform
TypeHardware Sales
Description

The CELLviewer lab-on-chip system is offered as part of the company's product portfolio for nutraceutical functional testing applications, targeting researchers and companies in the food/nutraceutical sector.

celldynamics.it
3PODA-3D Platform (in development)
TypeHardware Sales
Description

The PODA-3D project aims to deliver certified prototypes and advanced software for automated 3D cell model testing, intended for industrial implementation in pharma drug development workflows.

celldynamics.it
4RNA Therapeutic Testing Services (CN3_S9_BAC_04)
TypeHardware Sales
Description

Advanced prototypes and data processing algorithms for RNA-based therapeutic screening in 3D cellular environments, developed in collaboration with IFOM Institute.

celldynamics.it
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1W8 Instrument — Enterprise Research Equipment
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing. Customers can book a tailored demo via the website. No public price list is available.

celldynamics.it
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CellDynamics iSrl designs, develops, produces, and markets the W8, an automated laboratory instrument that performs non-disruptive, label-free, real-time biophysical quantification (size, mass density, weight) of live 3D cell cultures (spheroids and organoids) at a throughput of 20 organoids per hour. The company also offers the CELLviewer lab-on-chip platform for 3D organoid culture management, monitoring, and nutraceutical compound testing, with all fluidics, optics, and image-based software analysis developed in-house.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Throughput of 20 organoids per hour for fully automated biophysical characterization, with sample recovery for downstream analysis
+4 more records
Product overview1 text field

CellDynamics iSrl offers a suite of innovative laboratory tools that synergize fluidics, optics, and sophisticated image-based software analysis for 3D cell model quantification. The core product portfolio consists of the W8 instrument, which provides automated structural quantification of 3D cell cultures through image-based analysis measuring size, mass density, and weight; and the CELLviewer platform, which enables 3D cell culture management, monitoring, and characterization for drug testing applications. Both products work together to enhance the utility of 3D cell cultures in disease modeling, drug testing, and tissue engineering by providing quantitative biophysical data.

Product and service2 records
1W8 Laboratory Instrument
CategoryLaboratory instrumentation for 3D cell analysis
Description

The W8 is an automated laboratory instrument that provides non-disruptive, label-free, sterile structural quantification of 3D cell models (organoids and spheroids) by measuring size (µm), mass density (fg/µm³), and weight (ng) at a throughput of 20 organoids per hour. Designed for samples ranging from 100–600 µm, the W8 enables sample recovery by size, mass density, or combined measurement for downstream analyses such as deep imaging, confocal microscopy, and drug testing. It is targeted at pharmaceutical and biotechnology research groups, academic and university research laboratories, and oncology centers conducting drug discovery, potency testing (IC50), compound permeation screening, and 3D cell model quality control.

2CELLviewer Platform
CategoryLab-on-chip platform for 3D cell culture and nutraceutical testing
Description

CELLviewer is a lab-on-chip technological platform for 3D cell culture management, growth monitoring, and characterization of organoids and spheroids, designed to standardize and improve reliability in drug testing and nutraceutical functional testing. It integrates with organoid culture workflows, with applications focused on intestinal, hepatic, and trophoblast organoid models, and supports advanced prototypes and data processing algorithms for RNA-based therapeutic screening in 3D cellular environments.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

TwinHelix serves as the exclusive distribution partner for CellDynamics in Italy. Contact: Emanuela Ariotti (emanuela.ariotti@twinhelix.eu).

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Altium serves as the distribution partner for CellDynamics across the USA — covering the Boston Area (Zachary Taylor), California (Molly Clement), and Texas (Sean Doctor).

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

PARALAB BIO serves as the distribution partner for CellDynamics in Spain and Portugal. Contact: Tel +34 94 603 5765, info@paralab-bio.es.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

SWIFT Analytical serves as the distribution partner for CellDynamics in the UK. Contact: Mebs Serve (info@swiftanalytical.com).

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

NEW CELL X serves as the distribution partner for CellDynamics in France. Contact: Carole Bou Chrouch (carole.bouchrouch@newcellx.fr).

69X Biosciences (Shanghai) Co., Ltd.
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

9X Biosciences serves as the distribution partner for CellDynamics in China. Contact: Dr. Jun Huang (jhuang@9xbio.com).

celldynamics.it
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

MITO KOGYO serves as the distribution partner for CellDynamics in Japan. Contact: Ryuzo Narita (ryu_narita@mitokogyo.co.jp).

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

AlphaChrom serves as the distribution partner for CellDynamics across Slovenia, Croatia, Kosovo, and Bosnia (Ines Topalovic Pitesa), and Serbia, Macedonia, and Montenegro (Milorad Ivetic & Anja Radakovic).

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Perlan serves as the distribution partner for CellDynamics in Poland. Contact: Joanna Zimniak (jzimniak@perlan.com.pl).

10Izasa Scientific
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Izasa Scientific serves as an additional distribution partner for CellDynamics in the Iberian region (Spain). Contact: Silvia Fernandez Soriano (izasa@izasascientific.com).

celldynamics.it
Strategic tierCoreTypeStrategic or Co-development Partner
Description

IFOM Institute is a strategic partner in the CN3_S9_BAC_04 project, conducting experimental work on 3D cell cultures and RNA therapeutics. CellDynamics leads the technological and algorithmic development while IFOM provides experimental biology capabilities for PDAC spheroid models and ASO drug testing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Catania is a collaborative partner in the MISE-funded nutraceutical platform project (€3.47M total), responsible for organoid culture conditions and testing using the CELLviewer system. The collaboration uses botanical extracts from the Mount Etna region in Sicily.

13University of Sassari
Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Sassari is a collaborative partner in the MISE-funded nutraceutical platform project (€3.47M total), responsible for organoid culture conditions and testing using the CELLviewer system. The collaboration also focuses on botanical extracts from Sardinia, including those recovered from agri-food waste.

celldynamics.it
Strategic tierMinorTypeStrategic or Co-development Partner
Description

PODA-3D is a multi-institutional precision oncology project that integrates automated liquid handling systems with CellDynamics' W8 technology for standardized 3D tumor model drug testing. Focus areas include breast cancer and glioblastoma spheroids.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Thermo Fisher offers a comprehensive portfolio of life-science instruments, imaging systems, and cell analysis tools. While not focused on organoid mass density specifically, it competes broadly for the same pharma/biotech instrumentation budgets CellDynamics targets.

TypeDirect peer
Description

Emulate develops organ-on-chip platforms (Liver-Chip, Lung-Chip) for predictive 3D cell modeling and drug response profiling. Like CellDynamics, Emulate operates at the intersection of microfluidics, organoid/3D culture, and pharma drug discovery applications.

3CN Bio
TypeDirect peer
Description

CN Bio offers PhysioMimix organ-on-chip systems for microphysiological 3D cell culture, drug metabolism, and toxicity testing. Both CellDynamics and CN Bio compete for pharma research dollars aimed at replacing 2D culture with standardized 3D/organoid workflows.

TypeDirect peer
Description

Mimetas develops the OrganoPlate, a microfluidic organ-on-chip platform for 3D cell culture and organoid-based drug screening. It is the closest functional peer to CellDynamics' CELLviewer lab-on-chip system, addressing overlapping pharma/biotech customers with standardized 3D model workflows.

TypeBroad incumbent
Description

Molecular Devices (Danaher) provides high-content imaging and screening instruments used for 3D cell culture and organoid analysis. It is a broader incumbent with overlapping biophysical/imaging functionality but a much larger pharma/biotech installed base.

TypeDirect peer
Description

InSphero provides 3D spheroid and organoid technology platforms, including assay-ready microtissues and characterization tools for drug discovery. Like CellDynamics, InSphero targets pharma/biotech customers seeking standardization and QC of 3D cell models.

7Cellesce
TypeEmerging player
Description

Cellesce specializes in the expansion and production of organoids at scale for drug discovery and research applications. It is an emerging player in the broader 3D cell culture / organoid ecosystem that intersects with CellDynamics' customer base and standardization value proposition.

TypeEmerging player
Description

CytoSMART (now part of Axion Biosystems) develops compact live-cell imaging devices for cell culture monitoring. It overlaps with CellDynamics in live-cell, label-free monitoring of 3D cultures but focuses on more accessible benchtop formats.

TypeBroad incumbent
Description

Sartorius supplies cell analysis instruments, bioreactors, and lab automation tools for biopharma R&D and manufacturing. It overlaps with CellDynamics in cell-based analytics and 3D cell culture workflow enablement, but as part of a much broader portfolio.

TypeBroad incumbent
Description

Revvity (formerly PerkinElmer) provides cell imaging, high-content analysis, and lab automation used in 3D cell culture and organoid research. It overlaps with CellDynamics' pharma/biotech customer base and could expand into biophysical QC features for spheroids/organoids.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CellDynamics iSrl

Laboratory Instrumentation for 3D Cell Analysiscelldynamics.it

CellDynamics iSrl firmographics

Firmographics
Name
CellDynamics iSrl
Legal name
CellDynamics ISRL
Website
https://celldynamics.it
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

CellDynamics iSrl industry classification

Industry
Product category
Laboratory Instrumentation for 3D Cell Analysis
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAGAD
Organoids & Organ-on-Chip (regenerative models)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • 3D cell analysis
  • Organoid quantification
  • Biophysical characterization
  • Spheroid measurement instruments
  • Lab automation hardware

Where CellDynamics iSrl is headquartered

Location

Headquarters

HQ city
Bologna
HQ country
Italy
HQ region
Europe

Offices4 records

Markets served

CellDynamics iSrl business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. W8 Hardware and Software Sales: CellDynamics designs, develops, produces, and markets the W8 instrument and associated software entirely in-house. Revenue is generated from the sale of the W8 platform to pharma, biotech, and academic research institutions for biophysical characterization of 3D cell models.
  2. CELLviewer Platform: The CELLviewer lab-on-chip system is offered as part of the company's product portfolio for nutraceutical functional testing applications, targeting researchers and companies in the food/nutraceutical sector.
  3. PODA-3D Platform (in development): The PODA-3D project aims to deliver certified prototypes and advanced software for automated 3D cell model testing, intended for industrial implementation in pharma drug development workflows.
  4. RNA Therapeutic Testing Services (CN3_S9_BAC_04): Advanced prototypes and data processing algorithms for RNA-based therapeutic screening in 3D cellular environments, developed in collaboration with IFOM Institute.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractW8 Instrument — Enterprise Research Equipment

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

CellDynamics iSrl product offering

Product offering

Core offering

CellDynamics iSrl designs, develops, produces, and markets the W8, an automated laboratory instrument that performs non-disruptive, label-free, real-time biophysical quantification (size, mass density, weight) of live 3D cell cultures (spheroids and organoids) at a throughput of 20 organoids per hour. The company also offers the CELLviewer lab-on-chip platform for 3D organoid culture management, monitoring, and nutraceutical compound testing, with all fluidics, optics, and image-based software analysis developed in-house.

Product overview

CellDynamics iSrl offers a suite of innovative laboratory tools that synergize fluidics, optics, and sophisticated image-based software analysis for 3D cell model quantification. The core product portfolio consists of the W8 instrument, which provides automated structural quantification of 3D cell cultures through image-based analysis measuring size, mass density, and weight; and the CELLviewer platform, which enables 3D cell culture management, monitoring, and characterization for drug testing applications. Both products work together to enhance the utility of 3D cell cultures in disease modeling, drug testing, and tissue engineering by providing quantitative biophysical data.

Differentiator

Problem solved

Functional benefit

Products and services

  • W8 Laboratory Instrument The W8 is an automated laboratory instrument that provides non-disruptive, label-free, sterile structural quantification of 3D cell models (organoids and spheroids) by measuring size (µm), mass density (fg/µm³), and weight (ng) at a throughput of 20 organoids per hour. Designed for samples ranging from 100–600 µm, the W8 enables sample recovery by size, mass density, or combined measurement for downstream analyses such as deep imaging, confocal microscopy, and drug testing. It is targeted at pharmaceutical and biotechnology research groups, academic and university research laboratories, and oncology centers conducting drug discovery, potency testing (IC50), compound permeation screening, and 3D cell model quality control.
  • CELLviewer Platform CELLviewer is a lab-on-chip technological platform for 3D cell culture management, growth monitoring, and characterization of organoids and spheroids, designed to standardize and improve reliability in drug testing and nutraceutical functional testing. It integrates with organoid culture workflows, with applications focused on intestinal, hepatic, and trophoblast organoid models, and supports advanced prototypes and data processing algorithms for RNA-based therapeutic screening in 3D cellular environments.

Quantifiable outcome

  • Throughput of 20 organoids per hour for fully automated biophysical characterization, with sample recovery for downstream analysis
  • +4 more outcomes

Companies that use CellDynamics iSrl

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles3 records

CellDynamics iSrl technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

CellDynamics iSrl partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and minor.

  • TwinHelixcoreChannel Partner/ Reseller/ DistributorTwinHelix serves as the exclusive distribution partner for CellDynamics in Italy. Contact: Emanuela Ariotti (emanuela.ariotti@twinhelix.eu).
  • AltiumcoreChannel Partner/ Reseller/ DistributorAltium serves as the distribution partner for CellDynamics across the USA — covering the Boston Area (Zachary Taylor), California (Molly Clement), and Texas (Sean Doctor).
  • PARALAB BIOcoreChannel Partner/ Reseller/ DistributorPARALAB BIO serves as the distribution partner for CellDynamics in Spain and Portugal. Contact: Tel +34 94 603 5765, info@paralab-bio.es.
  • SWIFT AnalyticalcoreChannel Partner/ Reseller/ DistributorSWIFT Analytical serves as the distribution partner for CellDynamics in the UK. Contact: Mebs Serve (info@swiftanalytical.com).
  • NEW CELL XcoreChannel Partner/ Reseller/ DistributorNEW CELL X serves as the distribution partner for CellDynamics in France. Contact: Carole Bou Chrouch (carole.bouchrouch@newcellx.fr).
  • 9X Biosciences (Shanghai) Co., Ltd.coreChannel Partner/ Reseller/ Distributor9X Biosciences serves as the distribution partner for CellDynamics in China. Contact: Dr. Jun Huang (jhuang@9xbio.com).
  • MITO KOGYOcoreChannel Partner/ Reseller/ DistributorMITO KOGYO serves as the distribution partner for CellDynamics in Japan. Contact: Ryuzo Narita (ryu_narita@mitokogyo.co.jp).
  • AlphaChromcoreChannel Partner/ Reseller/ DistributorAlphaChrom serves as the distribution partner for CellDynamics across Slovenia, Croatia, Kosovo, and Bosnia (Ines Topalovic Pitesa), and Serbia, Macedonia, and Montenegro (Milorad Ivetic & Anja Radakovic).
  • PerlancoreChannel Partner/ Reseller/ DistributorPerlan serves as the distribution partner for CellDynamics in Poland. Contact: Joanna Zimniak (jzimniak@perlan.com.pl).
  • Izasa ScientificcoreChannel Partner/ Reseller/ DistributorIzasa Scientific serves as an additional distribution partner for CellDynamics in the Iberian region (Spain). Contact: Silvia Fernandez Soriano (izasa@izasascientific.com).
  • IFOM Institute (Istituto di Ricerca e Cura Cancer Campus)coreStrategic or Co-development PartnerIFOM Institute is a strategic partner in the CN3_S9_BAC_04 project, conducting experimental work on 3D cell cultures and RNA therapeutics. CellDynamics leads the technological and algorithmic development while IFOM provides experimental biology capabilities for PDAC spheroid models and ASO drug testing.
  • University of CataniacoreStrategic or Co-development PartnerUniversity of Catania is a collaborative partner in the MISE-funded nutraceutical platform project (€3.47M total), responsible for organoid culture conditions and testing using the CELLviewer system. The collaboration uses botanical extracts from the Mount Etna region in Sicily.
  • University of SassaricoreStrategic or Co-development PartnerUniversity of Sassari is a collaborative partner in the MISE-funded nutraceutical platform project (€3.47M total), responsible for organoid culture conditions and testing using the CELLviewer system. The collaboration also focuses on botanical extracts from Sardinia, including those recovered from agri-food waste.
  • PODA-3D Consortium (Implied Collaboration)minorStrategic or Co-development PartnerPODA-3D is a multi-institutional precision oncology project that integrates automated liquid handling systems with CellDynamics' W8 technology for standardized 3D tumor model drug testing. Focus areas include breast cancer and glioblastoma spheroids.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

CellDynamics iSrl competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher offers a comprehensive portfolio of life-science instruments, imaging systems, and cell analysis tools. While not focused on organoid mass density specifically, it competes broadly for the same pharma/biotech instrumentation budgets CellDynamics targets.
  • Molecular Devices: Molecular Devices (Danaher) provides high-content imaging and screening instruments used for 3D cell culture and organoid analysis. It is a broader incumbent with overlapping biophysical/imaging functionality but a much larger pharma/biotech installed base.
  • Sartorius: Sartorius supplies cell analysis instruments, bioreactors, and lab automation tools for biopharma R&D and manufacturing. It overlaps with CellDynamics in cell-based analytics and 3D cell culture workflow enablement, but as part of a much broader portfolio.
  • PerkinElmer (Revvity): Revvity (formerly PerkinElmer) provides cell imaging, high-content analysis, and lab automation used in 3D cell culture and organoid research. It overlaps with CellDynamics' pharma/biotech customer base and could expand into biophysical QC features for spheroids/organoids.

Direct peers

  • Emulate: Emulate develops organ-on-chip platforms (Liver-Chip, Lung-Chip) for predictive 3D cell modeling and drug response profiling. Like CellDynamics, Emulate operates at the intersection of microfluidics, organoid/3D culture, and pharma drug discovery applications.
  • CN Bio: CN Bio offers PhysioMimix organ-on-chip systems for microphysiological 3D cell culture, drug metabolism, and toxicity testing. Both CellDynamics and CN Bio compete for pharma research dollars aimed at replacing 2D culture with standardized 3D/organoid workflows.
  • Mimetas: Mimetas develops the OrganoPlate, a microfluidic organ-on-chip platform for 3D cell culture and organoid-based drug screening. It is the closest functional peer to CellDynamics' CELLviewer lab-on-chip system, addressing overlapping pharma/biotech customers with standardized 3D model workflows.
  • InSphero: InSphero provides 3D spheroid and organoid technology platforms, including assay-ready microtissues and characterization tools for drug discovery. Like CellDynamics, InSphero targets pharma/biotech customers seeking standardization and QC of 3D cell models.

Emerging players

  • Cellesce: Cellesce specializes in the expansion and production of organoids at scale for drug discovery and research applications. It is an emerging player in the broader 3D cell culture / organoid ecosystem that intersects with CellDynamics' customer base and standardization value proposition.
  • CytoSMART: CytoSMART (now part of Axion Biosystems) develops compact live-cell imaging devices for cell culture monitoring. It overlaps with CellDynamics in live-cell, label-free monitoring of 3D cultures but focuses on more accessible benchtop formats.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

CellDynamics iSrl social profiles

Digital presence

CellDynamics iSrl financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CellDynamics iSrl leadership team

Management profile

Number of profiles

CellDynamics iSrl funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CellDynamics iSrl M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CellDynamics iSrl

What does CellDynamics iSrl do?

CellDynamics iSrl designs, develops, produces, and markets the W8, an automated laboratory instrument that performs non-disruptive, label-free, real-time biophysical quantification (size, mass density, weight) of live 3D cell cultures (spheroids and organoids) at a throughput of 20 organoids per hour. The company also offers the CELLviewer lab-on-chip platform for 3D organoid culture management, monitoring, and nutraceutical compound testing, with all fluidics, optics, and image-based software analysis developed in-house.

Is CellDynamics iSrl a public or private company?

CellDynamics iSrl is a private company. It is classified as unknown and is currently operating.

When was CellDynamics iSrl founded?

CellDynamics iSrl was founded in 2013. It employs 11 to 50 people.

Where is CellDynamics iSrl based?

CellDynamics iSrl is headquartered in Bologna, Italy, in the Europe region.

How does CellDynamics iSrl make money?

Four revenue lines are on record. W8 Hardware and Software Sales are the primary driver. The others are CELLviewer Platform, PODA-3D Platform (in development) and RNA Therapeutic Testing Services (CN3_S9_BAC_04).

Who are CellDynamics iSrl's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, Molecular Devices, Sartorius and PerkinElmer (Revvity). Direct peers are Emulate, CN Bio, Mimetas and InSphero. Emerging players are Cellesce and CytoSMART.

Does CellDynamics iSrl have an API?

No public API is recorded for CellDynamics iSrl.

What industry is CellDynamics iSrl in?

CellDynamics iSrl's product category is Laboratory Instrumentation for 3D Cell Analysis. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAAAIAJ, In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales